ML20140H304
| ML20140H304 | |
| Person / Time | |
|---|---|
| Site: | 07002427 |
| Issue date: | 04/04/1997 |
| From: | Michelle Beardsley NRC OFFICE OF INSPECTION & ENFORCEMENT (IE REGION I) |
| To: | |
| References | |
| 124319, NUDOCS 9706180155 | |
| Download: ML20140H304 (26) | |
Text
_ __
____-__m m m ou
,,o oooooooooooooooooooe g
y,R U.S. NUCLEAR REGULATORY COMMISSIO E I
& 3 NES FORM 374 y
MATERIALS LICENSE Amendment No. 08 g
g Pursuant to the Atomic Energy Act of 1954, as amended, the Energy Reorganization Act of 1974 (Public Law 93-438), and Title 10 Code of e g Federal Regulations. Chapter I, Parts 30,31,32,33,34,35,36,39,40, and 70, and in reliance on statements and representations heretofore made by the licensee, a license is hereby issued authorizing the licensee to receive, acquire, possess, and transfer byproduct, source, and special nu g
N material designated below; to use such material for the purpose (s) and at the place (s) designated below; to deliver or transfer such material to L
persons authorized to receive it in accordance with the regulations of the applicable Part(s). This license shall be deemed to contai specified in Section 183 of the Atomic Energy Act of 1954, as amended, and is subject to all applicable rules, regulations, and orders of the 3
Nuclear Regulatory Commission now or hereaf ter in effect and to any conditions specified below.
9 0FRCIALRECORDCOPY a
e In accordance with the letter dated j
3 ebrua g ',SNM-1690 is amended in F
- 1997, E
' Kennedy Memorial Hospitals
'ee'""
E University Medical Center its entirety to read as follows:
1 E
Stratford Division i
218 East Laurel Road l
Stratford, New Jersey 08084 4 B iration Date June 30, 2002 P
C
- 5. Docket or i
Reference No.
070-02427 i
g
- 6. Byproduct Source, and/or 7, Chemical and/or Physical
- 8. Maximum Amount that Licensee a
Special Nuclear Material Form j
May Possess at Any One Time l
Under This License li i,
\\
lE A. Plutonium (principal A. Sealed Source A. 2.5 grams (individual i
i radionuclide Pu-238) sources not to exceed i
E 250 milligrams each) 5 8. Plutonium (principal B. Sealed Source B. 2.25 grams (individual i
radionuclide Pu-238) sources not to exceed i
- 8 225 milligrams each) l C. Plutonium (principal C. Sealed Source C. 2.5 grams (individual I"l radionuclide Pu-238) sources not to exceed
{$ll 5
250 milligrams each)
(
9.
Authorized use i
l l
A.
As a componeitt of Coratomic Model C-101 nuclear-powered cardiac pacemakers for k
lE clinical evaluation in accordance with manufacturer's protocol dated November 1, d]
1985, this authorization includes: follow-up, explantation, recovery disposal and implantation.
z lS i
j?j B.
As a component of Cordis Nuclear Omni-Stanicor Model 184A nuclear-powered cardiac pacemakers for clinical evaluation in accordance with manufacturer's protocol dated IS October 30, 1974, this authorization includes: follow-up, explantation, recovery i
3 disposal, but not implantation.
3 C
As a component of Coratomic Model C-101-P nuclear-powered cardiac pacemakers for clinical evaluation in accordance with manufacturer's protocol dated March 2,1983, 33 L5 this authorization includes: follow-up, explantation, recovery disposal and 5
implantation.
3
~i 9
2 3
! B-l=f CONDITIONS N
10.
Licensed material shall be used only at the licensee's facilities located at hl' g
Kennedy Memorial Hospital,18 E. Laurel Road, Stratford, New Jersey.
3 E;11.
A.
The physicians responsible for implantation, follow-up, explantation, and return f 9
of nuclear-powered pacemakers to the manufacturer for proper di posal are j B Louis A. Papa, D.0. and P. Todd Makler, M.D.
0 q
\\ML 10
- W lilHIEll!llEEllMilli W
9706180155 970404
- ---- m -m m m m m m m m m m adl PDR ADOCK 07002427 i" * * * * * --
4 C
PDR P"'"d a a*d rar" s
mL}E W A )El 55 Y I 555555 I 55555 555 5 515 EI I 55 EN5 5 I55 T
t l
!!RC FORM 374A U.
CLEAR *REOULAToRY COMMISSION 2
3 gl PAGE or p cts License Ndal gl SNM-1690 g
l g
MATEIUALS LICENSE Docket or Reference N gi l
g SUPPLEMENTARY SHEET
(
f; I
Amendment No. 08 4
B.
The Radiation Safety Officer for this license is P. Todd Makler, M.D.
f, fl i
- 12. The specified possession limit for cardiac pacemakers includes all licensed material l
N possessed by the licensee under this license whether in storage, implanted in m
l patients, or otherwise in use.
N 13. The licensee shall report to the U.S. Nuclear Regulatory Commission, Region I, AT1N:
E!
N Clief, Nuclear Materials Safety Branch, 475 Allendale Road, King of Prussia, l
N Pennsylvania 19406, within 24 hours2.777778e-4 days <br />0.00667 hours <br />3.968254e-5 weeks <br />9.132e-6 months <br /> of occurrence, the death of any nuclear pacemaker El l
N patient, and any adverse reaction and/or malfunction involving a pacemaker system, El l
N including the leads. A written report giving details of the adverse reaction and/or E
ll l
N malfunction shall be submitted within 30 days.
E l
N E '
i B 14. The licensee shall report to the U.S. Nuclear P.
4*ory Commission, Region I, ATTN:
El l
g Chief, Nuclear Materials Safety Branch, 475 Allebale Road, King of Prussia, El l
W Pennsylvania 19406, within 10 days of loss of contact with a nuclear pacemaker El 1
g patient.
El W
E; l
g 15. The licensee shall not receive or transfer in any single transaction one (1) gram or l
l l
g more of plutonium 238 contabcd in nuclear-powered pacemakers without notifying the f ll l
q Division of Safeguards, U.S..N elear Regulatory Commission, Washington, D.C.
- 20555, g
and, in addition, completine ud distributing Form NRC-741 as required by Section j ll g
70.54 of 10 CFR 70.
u i
j 16. The licensee shall continue patient follow-up and replacement procedures for the l
l g
nuclear pacemaker during the life of the patient. Procedures for recovery and j l g
authorized disposal of the nuclear pacemaker by return to the manufacturer shall be
{l y
followed upon the death of the patient.
j R
l y 17. Sealed sources or detector cells containing licensed material shall not be opened or l l l
g sources removed from detector cells by the licensee.
l l l 18. The licensee may transport licensed material in accordance with the provisions of f
g 10 CFR Part 71, " Packaging and Transportation of Radioactive Material".
N E!
R E
W El W
El N
El l
E M
El 4
u El W
El W
El E1 m
31l W
E n
El!
El u
E W
E M M M M5E& M M MNE M M M M M SNEEEEEENN.55$ M M MEE????? 5 5?E #
Prmied on ercyrleJ Nper
p_NRw_y_w3Ontww.w_wjonOICJOirsr'IrsOirJOh JOiffirsTFirsOiBiBiOsOiOiOL3ifiirEJrJOicaOirs/iirJTGc FORM 374 A U.
CLEAR
- REGULATORY COMMISslON k
PAGE 3
or 3 p4ces
[
g LKense Ndd g
SNM-1690 g
y MATERIALS LICENSE g
Daket or Reference N r
(!
i g
SUPPLEMENTARY SHEET
-02427
-g l
f Amendment No. 08 M
E'l 5 19. Except as specifically provided otherwise in this licen e, the licensee shall conduct N!
E its program in accordance with the statements, representations, and procedures l
contained in the documents, including any enclosures, listed below, except for minor
{i 5
N changes in the medical use radiation safety procedures as provided in 10 CFR 35.31.
$l 5
The U.S. Nuclear Regulatory Commission's regulations shall govern unless the 3
51 statements, representations, and procedures in the licensee's application and g"l f
correspondence are more restrictive than the agulations, d
d e!
i A.
Application trans nitted with letter dated October 7,1976 E
B.
Letter dated March 3, 1977 C.
Letter dated October 4, 1977
$l D.
Letter dated December 18, 1991 tl E.
Letter dated May 19, 1992 El B
El g
E ll W
E W
El M
El 3
El 5
$l N
tl M
h Yl M
El B,
~
3 5!
gi 3
i 3
5l 3
ci M
$l 3
5l E
B El 1
$ll N
9 M
5l
\\
R 5l 3
5l s'
.tl 3
il W
il W
,l N,
il i
l N For the U.S. Nuclear Regulatory Commission
!l APR - 4 799/
Original Signed By:
Il 5
N Date Michelle Beardsley Ill I
N
~
By N
Nuclear Materials Safety Branch il 5
Region I
!l A
K % of Prussia, Pennsylvania 19406 g;
gl k
e
% m m m mun m m m m m2susCirunausWERWE2'2%2x22C"3X"E "22 "M5kATEE Pr mied on reorieJ perer
l APR - 4 1997 Joseph W. Devine VP Hospital Services Kennedy Memorial Hospitals University Medical Center Stratford Division 18 East Laurel Road Stratford, NJ 08084 l
Dear Mr. Devine:
This refers to your license amendment request. Enclosed with this letter is the amended license. Please note that as part of this amendment, in accordance with 10 CFR 30.36, effective February 15,1996, the expiration date cf your license has been extended by a period of five years. Your new expiration date is stated in item 4 of the license.
Please review the enclosed document carefully and be sure that you understand and l
fully implement all the conditions incorporated into the amended license. If there ere l
any errors or questions, please notify the U.S. Nuclear Regulatory Commission, Region l Office, Licensing Assistance Team, (610) 337-5093 or 5239, so that we can provide appropriete corrections and answers.
Thank you for your cooperation.
4 Sincerely,
- Original Signed By:
Michelle Beardsley Michelle R. Beardsley D' rision of Nuclear Materials Safety License No. SNM 1690 Docket No. 070-02427 l
Control No. 124319 r
i
Enclosure:
Amendment No. 08 i
N OFFICIAL RECORD COPY t
3 4
O O
i-l.. l I
l l
l t
i i
l l
i l
l l
1 l
DOCUMENT NAME: R:\\WPS\\MLTR\\LSNM1690 To receive a copy of this document, ind6cate in the box: 'C' = Copy w/o attach /enci
- E' = Copy w/ attach /enci
'N" = No copy OFFICE DNMS/RI
,K lN DNMS/RI l
NAME Beardsley yW
.q 0 ATE 03/03/97 03/ /97 03/ /97 03/ /97 4
-w 1
i I
OFFICIAL RECORD COPY 4
I l
KENNED?
9 Kennedy Memorial Hospitals Uliversity Medical Center Stratford Disision 18 E. Laurel Road Stratford, NJ 08084 609-346-6(X)0 February 14, 1997 g
10' 0 0
Mr. Frank Costello Chief Medical Licensing Section Nuclear Regulatory Commission Region I 475 Allendale Road King of Prussia, PA 19406-1414
SUBJECT:
Amendment to Corotomic License Number SNM-1690
Dear Mr. Costello:
The following changes to the Corotomic License are requested.
Please change the Radiation Safety Officer for this license.
Harvey A.
- Koolpe, M.D.
will resign and be replaced by P.
Todd
- Makler, M.D.
Dr. Makler is already on our license for uses specified in 35.100, 35.200, 35.300, and 35.500.
Dr. Makler received board certification from the Ameri can Board of Nuclear Medicine in 1976.
Copies of his board certifications and curriculum vitae are enclosed.
The Administrative Representative has been changed from C.
Barry Dykes to Joseph W.
Devine, V.P.
Hospital Services.
(
Please remove Harvey A. Koolpe as one of the physicians responsible for implantation, follow-up, and return of the pacemaker and add P.
l Todd Makler, M.D.
along with Louis A.
- Papa, D.O.
l Thank you for your assistance with this matter.
I cerely, mc/a401 A iosep'n W. Devine ice President of Hospital Services Enclosure 124319 0FFICIALRECORDCOPY ML10 FEB 2 71997 The MajorTeaching Affiliate ofib University of Medicine and Dentistry of NewJersey New Jersei Lchool of Osteopathic Medicine
O O
~
Curriculum Vitae P. Todd Makler. Jr.. M.D.
i It/n/1r
~_: ~
- q Home Address:
Social Security No:
Date of Birth:
Place of Birth:
Marital Status:
Education:
1964-68 B.A., University of Pennsylvania. Philadelphia, Pennsylvania 1968-7-2 M.D., University of Pennsylvania Medical School, Philadelphia, Pennsylvania Posteraduate Trainine nnd Fellowshin Anoointments:
/
1972-1973 Intern, Medicine, Graduate Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 1973-1976 Resident, Nuclear Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania Hosoital Anoointments:
1976-1980 Attending StaffRadiologist, Section of Nuclear Medicine, Department of Radiology, Temple University Hospital, Philadelphia, Pennsylvania 1980-1985 Artending StafRadiologist, Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 1985-1993 Senior Attending StaffRadiologist, Division of Nuclear Medicine, Albert Einstein Medical Center, Philadelphia, Pennsylvania 1990-1993 Chief, Division ofNuclear Medicine, Department of Radiology, Albert Einstein Medical Center, Philadelphia, Pennsylvania 1993-1994 Consultant, Division of Nuclear Medicine, Kennedy Hospitals -
Stratford Division, New Jersey 1994-Chief, Division of Nuclear Medicine, Kennedy Hospitals - Stratford Division, New Jersey i
i 1
i i
~
\\*
P. Toc ^4 alder, Jr., M.D.
\\/
Academic Anpointments:
1976-1977 Instructor ofNuclearMedicine, Temple University School of Medicine, Philadelphia, Pennsylvania 1977-1980 Assistant Professor ofRadiology, Section of Nuclear Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania 1980-1982 Assistant Professor ofRadiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 1982-1985 Associate Professor ofRadiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 1985-1990 Clinical Associate Professor ofRadiology, Temple University School of Medicine, Philadelphia, Pennsylvania 1990-1993 Clinical Professor ofRadiology, Temple University School of Medicine, Philadelphia, Pennsylvania 1994-Associate Professor ofRadiology, University of Medicine and Dentistry of New Jersey, Stratford, NJ Other Appointments:
1986-1993 Member, Board ofDirectors, Elkins Park Radiology Associates 1991-1993 Secretary / Treasurer, Elkins Park Radiology Associates and Center One Radiology Associates Certification:
1976 American Board of Nuclear Medicine Licensure:
1972 Pennsylvania (#MD-035326-L) 1994 New Jersey
(#MA-60362)
Awards:
1964 National Merit Scholarship Winner Membershin in Professional Societies:
NationalSocieties:
Society of Nuclear Medicine American College of Nuclear Physicians Fellow, American College of Nuclear Physicians Fellow, American College of Cardiology LocalSocieties:
Greater New York Chapter of the Society of Nuclear Medicine Pennsylvania College of Nuclear Medicine 2
P. Tp'jMalder, Jr., M.D.
g
's /
V
)
Committees and Orrices in Professional Societies:
Society ofNuclearMedicine:
~
1951-1993 Member, Nominating Committee 1992-Member, Finance Committee 1992-Member, Coding /CPT Committee 1993-Member, Government Relations Special Committee American College ofNuclear Physicians:
1991 -
Member, Board of Delegates 1992 -
Member, Coding Committee 1992 -
Member, Finance Committee 12/92-3/93 Vice Chairman of Finance Committee 3/93 -
Chairman of Finance Committee 1993-Member, Ad Hoc Committee on Strategic Financial Review American College ofNuclear Medicine:
1991-1994 Member, Board of Regents Greater New York Chapter of the Society ofNuclear Medicine:
1983-Member, Board of Governors s
1983-1986 Chairman, Education Committee 1983-1986 Member, Bylaws Committee 1984-1986 Member, Membership Committee 1986-1989 Secretary 1987-1990 Member, Program Committee 1989-1991 Chairman, Technologist Liaison Committee 1989-1991 President Elect 1991-1993 President 1993-1994 Treasurer 1993-1995 Chairman, Nominating Committee Pennsylvania College ofNuclear Medicine:
1990-Treasurer GreaterDelaware Valley Nuclear Cardiology Group:
1980-1982 President and Founder Philadelphia County Medical Society Interspecialty Panel 1991-95 NuclearMedicine Representative 1992-95 Member, Governing C6uncil Nuclear Cardiology Working Group ofthe Delaware Valley 1993-95 Founding Member 3
P. T Makler, Jr., M.D.
Pennsylvania Blue Shield:
1992-3 Nuclear Medicine Representativefor State ofPennsylvania, Carrier Advisory Committe.e Blue Cross ofPennsylvania:
1993-Consultant for Nuclear Medicine Committees at Albert Einstein Medical Center:
1986-93 Member, Quality Assurance Committee, Division of Nuclear Medicine 1988-93 Radiology Representative, Medical Records Quality Assessment and Improvement Group 1991-92 Member, Search Committee for Chief of Radiology l
Principle Investigator of Funded Grants:
CENTOCOR Multicenter Clinical Trial of the Safety and Diagnostic Accuracy of 1987-1988 Indium-111 Labeled Antimyor,in for Detecting Myocardial Necrosis in Ischemic Heart Disease CENTOCOR Evaluation of the Safety and Preliminary Diagnostic Accuracy of l
1987-1988 Technetium-99m Labeled Antifibrin T2G1s Fab' Monoclonal Antibody in Patients with Deep Venous Thrombosis CENTOCOR Evaluation of the Safety and Preliminary Diagnostic Accuracy of l
1987-1988 Technetium-99m Labeled Antifibrin T2Gls Fab' Monoclonal l
Antibody in Patients with Pulmonary Embolism i
CENTOCOR Evaluation of the Safety, Diagnostic Accuracy and Clinical Utility of l
1988-1989 Technetium-99m labeled T2Gls Antifibrin Fab' Monoclonal l
Antibody in Patients with Clinically Suspected Deep Venous Thrombosis CENTOCOR The Safety and Diagnostic Accuracy of Delayed and Repeated 1988-1991 Injections ofIndium-111 Labeled Antimyosin in Ischemic Heart Disease CENTOCOR Evaluation of the Safety, Performance Characteristics and Clinical 1
1989-1991 Utility of Technetium-99m Labeled T2Gis Antifibrin Fab' l
Monoclonal Antibody in Patients with Signs and Symptoms of Deep
(
Venous Thrombosis CENTOCOR Evaluation of the Safety, Performance Charactedstics and Clinical 1989-1991 Utility of Technetium-99m Labeled T2G1s Antifibrin Fab' Monoclonal Antibody in Patients ct High Risk for Developing Deep Venous Thrombosis 4
4 CENTOCOR Evaluation of the Safety, Preliminary Diagnostic Accuracy and 1990-1 Clinical Utility of Technetium-99m Labeled S12 Fab' Monoclonal Antibody in Patier/ s with Pulmonary Embolism f
1 4
4 1
P. TcOAakler, Jr., M.D.
~
\\- /
MEDCO RESEARCH INC. A Phase I/II Dose Ranging, Safety, and Preliminary Efficacy Study 1992-3 of 1231-IPPA as an Imaging Agent for the Assessment of Viable Myocardium and the Ability to Predict Functional Recovery.
Non-Professional Activities:
Athletics 1965 Member of the United States Fencing Team to the World Championships in Paris (Epee) 1966/67 NCAA Individual Fencing Champion (Saber)
L 1967/68 NCAA Individual Fencing Champion (Saber) 1972 Member of the United States Olympic Fencing Team (Epee)
Abington Friends Monthly Meeting i
1982-5 Member of Contribution Review Committee 1985-90 Memberof the AuditCommittee, 1989-90 Clerk of the Audit Committee 1988-Member of the Finance Committee of the Trustees of Abington Friends Monthly Meeting 1991 Treasurer of the Trustees of Abington Friends Monthly Meeting Philadelphia Yearly Meeting 1994 Budget Review Committee Abington Friends School
)
1985-90 Planned Giving Committee, Abington Friends School i
1991-Investment Sub Committee of the Abington Friends School Finance Committee i
Miscellaneous Professional Activities:
1993-Consultant on Nuclear Medicine billing procedures to GMIS Editorial Positions:
1977-1980 Reviewe r, Journal ofNuclear Medicine 1990 Reviewer, Journal ofNuclear Medicine 1983-1985 Reviewer, International Journal of Cardiology 1983-1985 Reviewer, American JournalofCardiology l
l t
i k
5
P. Tof'Makler, Jr., M.D.
(.
U
~~
t BIBLIOGRAPHY:
Original Articles:
1.
Kuhl D$, Sanders TD, Edwards RQ, Makler FT Jr: Failure to improve observer performance with scan smoothing. J Nucl Med 13:752-757, October 1972.
2.
Makler FT Jr, Eymontt MJ, Bloch P, Koch K: Effect of small amounts of 131I on 99mTc detection by the scintillation camera. J Nucl Med 17:1100-1101, December 1976.
3.
Makler FT Jr, Gutowicz MF: Focal encephalitis presenting as a dumbbell-shaped lesion crossing midline. Clin Nucl Med 2:8-9,1977.
4.
Makler PT Jr, Malmud LS, Charkes ND: Case Report: Metastatic thyroid carcinoma presenting as a hypervascular neck lesion. Clin Nucl Med 2:192-193, 1977.
5.
Makler PT Jr, Malmud LS, Charkes ND: Diminished perfusion to an entire lung due to mucus plug. Clin Nucl Med 2:160-162,1977.
6.
Makler PT Jr, Gutowicz MF, Kuhl DE: Methotreaxate-induced ventriculitis:
Appearance on routine radionuclide scan and emission computed tomography. Clin Nucl Med 3:22-23,1978.
7.
Charkes ND, Makler PT Jr, Philips C: Studies of skeletal tracer kinetics: I.
l Digital-computer solution of a five-compartment model of(18F) fluoride kinetics in humans. J Nucl Med 13:1301-1309, December 1978.
8.
Tolin R, Malmud LS, Menin R, Makler PT Jr, Reilley J, Fisher RS: Relationship of gastric to gallbladder emptying in health and disease. Clin Res 26:327,1978.
9.
Tolin R, Malmud LS, Reilley J, Makler PT Jr, Fisher RS: Esophageal clearance in patients with esophageal disorders. Gastroenterology 75: 1105,1978 10.
Makler FT Jr, Charkes ND, Malmud LS: Calculation of net renal uptake curves without use of a blood pool agent. Eur J Nucl Med 4:339-342, October 1979.
l 11.
Tolin RD, Malmud LS, Makler, PT Jr, Fisher RS: Esophageal clearance in patients with esophageal disorders. Eur J Nucl Med 4:140,1979.
12.
Malmud LS, Tolin R, Stelzer F, Makler PT Jr, Fisher RS:. Correlation of gastric and gallbladder emptying by dual isotope scintigraphy. Eur J Nucl Med 4:141, 1979.
13.
Tolin RD, Malmud LS, Stelzer F, Menin R, Makler PT Jr, Applegate G, Fisher RS: Enterogastric reflux in normal subjects and patients with Bilroth II gastroenterostomy. Measurement of enterogastne reflux. Gastroenterology 4
77:1027-1033, November 1979.
14 Makler PT Jr, Ledennan S, Charkes ND, Malmud LS, Warner H Reilley JJ:
Myocardial infaret imaging with 99mTc-pyrophosphate and 99mTc-methylene diphosphonate: Lack of correlation. Clin Nucl Med 4:89-91, March 1979.
6
P. Togakler, Jr., M.D.
15.
Charkes ND, Brookes M, Makler PT Jr: Studies of skeletal tracer kinetics: II.
Evaluation of a five-compartment model of(18F) fluoride kinetics in rats. J Nuc1 Med 20:1150-1157, November 1979.
16.
Makler Fr Jr, Lewis E, Cantor R, Charkes ND, Malmud LS: Nonvisualization of the left lobe of the liver due to atrophy or aplasia. Clin Nuc1 Med 5:63-65,1980.
17.
Makler FT Jr, Charkes ND: Studies of skeletal tracer kinetics. IV. Optimum time delay for Tc-99m (Sn) methylene diphosphonate bone imaging. J Nucl Med 21:641-645, July 1980.
18.
Makler FT Jr, Denenberg B, Malmud LS, Charkes ND, Boshko L: Evidence for splenic sequestration ofin vivo-labeled erythrocytes. Clin Nuc1 Med 5:497-498, November 1980.
19.
Makler PT Jr, Lavine SJ, Denenberg BS, Bove AA, Idell S: Redistribution on the thallium scan in myocardia 1 sarcoidosis: Concise communication. J Nuc1 Med 22:428-432, May 1981.
20.
Charkes ND, Makler PT Jr: Studies in skeletal tracer kinetics. V. Computer-simulated Tc-99m (Sn) MDP bone-scan changes in some systemic disorders:
Concise communication. J Nuct Med 22:601-605, July 1981.
21.
Denenberg BS, Makler PT Jr, Bove AA, Spann JF: Normal left ventricular emptying in coronary anery disease at rest: Analysis by radiagraphic and equilibrium radionuclide ventriculography. Am J Cardiol 48:311-315, August 1981.
22.
Makler PT Jr, Denenberg B, Bove AA, Malmud LS, Spann JF: Point by point examination of the equilibrium gated radionuclide left sentricular time activity curve:
Validation by biplane angiography. Eur J Nucl Med 6:301-307,1981.
23.
Macoviak JA, Stephenson LW, Armenti F, Kelly AM, Alavi A, Makler PT Jr, Cox J, Palatianos G, Edmunds LH Jr: Electrical conditioning ofin situ skeletal muscle for replacement of myocardium. J Surg Res 32:492-439,1982.
24.
Makler PT Jr, McCarthy DM. Goldstein H, Eymontt MJ, Alavi A: Incidence of rapid resolution of defects on stress thallium scans. Clin Nucl Med 7:458-461, October 1982.
25.
Mdder PT Jr, McCenhy DM, Velchik MG, Goldstein HA, Alavi A: Fourier amplitude ratio: A new way to assess valvular regurgitation. J Nucl Med 24:204-207, March 1983.
26.
McFarland TM, McCarthy DM, Makler PT Jr, Josephson ME: Relation between site of ongin of ventricular tachycardia and n:lative Left ver/cicular myocardial perfusion and wall motion. Am J Cardiol 51:1329-1333, May 1,1983.
27.
Makler Fr Jr, McCarthy DM, London JW, Sandler MS, Alavi A: Fourier analysis of a gated blood-pool study during atrial flutter. J Nucl Med 24:713-715, August 1983.
l 7
l e
A
~
p P. Topiakler, Jr., M.D.
d V
I l
28.
Velchik MG, Hansell J, Makler FT Jr, Alavi A: An unusual cause of multiple splenic infarcts. Clin Nucl Med 8:444, September 1983.
29.
Makler FT Jr, Velchik MD, Weingrad T, Mandell G, Goldstein HA: Unusual appearance of a highly vascularlesion on Tc-99m DISIDA hepatobiliary scmtigraphy. Clin Nucl Med 8:483-485, October 1983.
30.
Velchik MG, Heyman S, Makler PT Jr, Goldstein HA, Alavi A: Bone scintigraphy: Differentiating benign corticalirreguladty of the distal femur from mahgnancy. J Nucl Med 25:72-74,1984.
31.
Makler FT Jr, Goldstein HA, Velchik MG, Sr adler M, Alavi A: Variatiou of the spleen-liver activity ratio due to a change in position. Clin Nucl Med 9:85-88, February 1984.
32.
Velchik MG, Makler PT Jr, Alavi A: Gallbladder carcinoma: Another cause of the distended photon-deficient gallbladderin cholescintigraphy. Clin Nucl Med 9:137-138, 1984.
i 33.
Makler FT Jr, Sherwin N, McCarthy DM, Alavi A: Detection of sclerosing ndenosis of the breast on a thallium scan. Clin Nucl Med 9:277-278, May 1984.
34.
Makler PT Jr, McCarthy DM, Kleaveland JP, Doherty JU, Velchik MG: Validation of Fourier amplitude ratio to quantitate valvular regurgitation. J Am Coll Cardiol 3:1482-1487, June 1984.
35.
Makler FT Jr, McCarthy DM, Bergey P, Marshall K, Bourne M, Velchik M, Alavi A: Multiple-bospital survey of ejection-fraction variability using a cardiac phantom.
j Nucl Med 26:81-84, January 1985.
36.
Noel AW, Makler FT Jr, Velchik MG, Yudd AP: Visualization of arterial grafts on a gastrointestinal bleeding scan. Clin Nucl Med 10:19-20, January 1985.
37.
McCarthy DM, Makler PT Jr: Accuracy ofleft ventricular ejection fraction using the nuclear stethoscope in left ventricular aneurysm. Ari J Cardiol 55:177-180, January 1,1985.
38.
McCarthy DM, Makler FT Jr: Potentiallimitations of quantitative thallium scanning. Am J Cardiol 55:215-217, January 1,1985.
39.
Makler PT Jr, McCarthy DM, Alavi A: Early changes in thallium distribution.
l Effect on quantitative analysis. Invest Radiol 20:9-16, January-February 1985.
40.
Velchik MG, Schwartz W, London JW, Makler PT Jr, Alavi A: Quantitative analysis ofliver function in percutaneous transhepatic biliary drainage patients.
Clin Nucl Med 10:80-85, February 1985.
41.
Yudd AP, Makler FT, Noel AW, Alavi A: Nonrotation of bowel. Possible pitfalls in Meckel's scanning. Clin Nucl Med 10:377-378, May 1985.
42.
Velchik MG, McCanhy K, Makler FT Jr, Alavi A: Serendipity and bone scintigraphy. Clin Nucl Med 10:517-519, July 1985.
8 O
~
P. Tod'~^4akler, Jr., M.D.
n V
U 43.
Yudd AP, Makler PT Jr: Extensive soft tissue uptake of technetium-99m MDP in a patient with breast cancer. Clin Nucl Med 10:525-526, July 1985.
44.
VelchikMG,MaklerPTJr, Alavi A: Osteomalacia. Animpostorof osseous metastasis. Clin Nuct Med 10:783-785, November 1985.
45.
Makler PT Jr, Velchik MG: Computers in nuclear imaging. IM - Internal Medicine for the Specialist 6:97,1985.
46.
Makler PT Jr, McCarthy DM, Velchik MG, Alavi A: Sources of variability in quantitative thallium analysis. Invest Radiol 20:803-807, November 1985.
47.
Feldman N, Makler PT Jr, Alavi A: A false-posi:!ve indium-111 labeled leukocyte scintigram in a patient with a painful hip prosthesis. Clin Nucl Med 11:38-39, January 1986.
48.
Feldman N, Makler PT Jr, Velchik MG: Visualization of the uterus on evaluation of transplanted kidneys. Clin Nucl Med 11:62-64, January 1986.
49.
Mann DL, Denenberg BS, Gash AK, Makler PF Jr, Bove AA: Effects of age on ventricular performance during graded supine exercise. Am Heart J l11:108-115, January 1986.
50.
Mishkin J, Makler FT Jr, Velchik MG: Bone imaging appearance of Pelligrini Stieda syndrome. Clin Nucl Med 11:291-292, April 1986.
51.
Mishkin J, Makler PT Jr, Velchik MG, McCarthy K. Technetium-99m DISIDA imaging in autosomal-dominant polycystic kidney. Clin Nucl Med 11:368, May 1986.
52.
Kleaveland JP, Reichek N, McCarthy DM, Chandler T Priest C, Muhammed A, Makler PT Jr, Hirschfeld J Jr: Effects of six-month afterload reduction therapy with hydralozine in chronic aortic regurgitation. Am J Cardiol 57:1109-1116, May 1,1986.
53.
Lucas-Fehm LM, Makler FF Jr, Shapiro B: Technetium-99m MDP uptake in chronic venous insufficiency. Clin Nucl Med 11:803, November 1986.
54.
Weber DA, Makler PT Jr, Watson EE, Coffey JL, Thomas SR, London J:
Radiation absorbed dose from technetium-99m-labeled bone imaging agents. Task Group of the Medical Internal Radiation Dose Committee, The Society of Nuclear Medicine. I Nuct Med 30:1117-1122, June 1989.
,J l
-. = - -. - - - -.. -
l
(~
P.To
}4akler, Jr., M.D.
A bstracts:
1.
Makler PT Jr, Eymontt MJ, Arger PH, Kuhl DE: Screening for renal disease by I
radionuclide detection of renal volume changes: Method and preliminary clinical results.
Presented at Radiological Society of North America, Chicago, Illinois, December 1975.
2.
Malmud LS, Fisher RS, Littlefield JL, Rosenberg R, Dessel S, Makler PT Jr, Charkes ND: The mode of action of albi:dc acid compound in the reduction of gastroesophagea1 reflux using the GE scintiscan. J Nucl Med 19:686,1978.
3.
Tolin R, Malmud LS, Menin R, Makler PT Jr, Reilley J, Fisher RS: A new dual isotope technique to correlate gall bladder and gastric emptying. J Nucl Med 19:738-739 1978.
4 4.
Tolin R, Malmud LS, Menin R, Reilley J, Makler P'r Jr, Fisher RS: Detection and quantitation ofintergastric reflux following Bilroth II surgery. J Nucl Med 19:738-739,1978.
j.
5.
Charkes ND, Makler PT Jr, Malmud LS, Dessel S, Reilley J: Optimizing bone scan timmg by companmental analysis of skeletal tracer kinetics. J Nuct Med 20:614, 1979.
j 6.
Stelzer F, Malmud LS, Fisher RS, Tolin R. Menin R, Makler PT Jr, Reilley J:
Quantitative gastrocholecystoscintigraphy: Comparison of response to an oral meal orIV cholecystokinin (CCK) J Nucl Med 20:621,1979.
7.
Malmud LS, Fisher RS, Stelzer F, Menin R, Makler PT Jr, Applegate G:
Quantitative gastrocholecystoscintigraphy (GCG): Enterogastric reflux (ERG)in normal symptomatic subjects and post-gastrectomy patients. J Nuct Med 20:632, 1979.
8.
Boshko L, Reilley J, Stern H, Makler PT Jr, Malmud LS, Charkes ND:
Optimization of red blood cell in vivo labeling time in patients. J Nucl Med Tech 7:120, 1979.
9.
Applegate G, Reilley J, Stelzer F, Makler Fr Jr, Fisher RS, Malmud LS: The techmque of gastrocholecystic scintigraphy (dual isotope scanning of the upper gastrointestinal tract). J Nucl Med Tech 7:120,1979.
10.
Malmud LS, Charkes ND, Makler PT Jr, Reilley J, Levin S: Comparison ofI-125 l
fS' inogen uptake testing (FUT) and contrast venography in the detection of deep l
.. thrombosis (DVT) in patients with hip surgery or fracture. J Nucl Med 21:34, 30.
11.
r;harkes ND, Brookes M, Makler FT Jr: Compartmental model of F18 fluoride
~
xinetics. J Nucl Med 19:688,1978.
12.
Sagar V, Piccone JM, Charkes ND, Makler Fr Jr: Bone blood flow and tracer uptake. J Nucl Med 19:705,1978.
10 i
~
p
. P. T Makler, Jr., M.D.
t 13.
Denenberg BS, Makler PT Jr, Bove AA, Malmud LS, Charkes ND, Spacq J:
Inability to detect coronary anery disease at rest by pattern c f ventricular emptying using contrast angiography and radionuclide angiography. Am J Cardiol 45:409, i
1979.
i 14.
Soulen RE, Makler PT Jr, Lederman S: Com for the detection ofleft ventricular asynergy. parison of non-invasive techniques Abstracts of the Association of University Radiologists,1981, p 73.
15.
. Makler PT Tr, Denenberg BS, Bove AA, Charkes ND, Malmud LS, Spann J:
Validation of the details of the radionuclide left ventricular time activity curve. J Nucl Med 22:9,1981.
Presented at Society of Nuclear Medicine, Las Vegas, Nevada, June 1981.
- 16.
McCarthy DM,14akler PT Jr, Alavi A, Kastor JA: Lack of clinical utility of increased lung thallium uptake in predicting multivessel coronan artery disease. J Nucl Med 22:82,1981.
i 17.
Charkes ND, Makler PT Jr: Computer simulated Tc99m bone scan changes in some systemic disorders. J Nucl Med 22:26,1981.
18.
Makler PT Jr, Alavi A, McCarthy DM: Incidence of rapid resolution of stress-induced thallium defects. Clin Res 29:654A,1981.
i i
Presented at American Federation of Clinical Research, Boston, Massachusetts, October 1981.
i 19.
McCarthy DM, Doherty JU, Makler PT Jr, Hess DA, Kastor JA: Utility of thallium myocardial perfusion imaging in women. Clin Res 29:655A,1981.
l 20.
McFarland T, McCarthy DM, Makler PT Jr, Kastor JA, Josephson ME:
Relationship between site of origin of ventricular tachycardia and relative m)ocardial perfusion and wall motion. Clin Res. 29:655A,1981.
21.
Makler PT Jr, Denenberg BS, Bove AA, Charkes ND, Malmud LS, Spann JF:
Validation of the details of the radionuclide left ventricular time activity curve m diastole and systole. Circulation 64:35,1981.
Presented at American Hean Association, Dallas, Texas, November 1981.
22.
McFarland TM, McCarthy DM, Makler PT Jr, Josephson ME: Relationship i
between the site of origin of ventricular tachycardia and relative myocardial perfusion and wall motion. Am J Cardiol 49:934,'1982.
23.
McCarthy DM, Doheny JU, Makler PT Jr, Hess DA: Utility of thallium -201 l
myocardial perfusion in women. Clin Res 30:205,1982.
24.
Makler PT Jr, McCanhy DM, Goldstein HA, Velchik MG, Alavi A: Fourier j
j amplitude ratio to assess aortic regurgitation by gated blood pool scan. Clin Res 30:674, 1982.
Presented at American Federation of Clinical Research, Boston, Masacitusetts, 1
October 1982.
i
}i-
~
11 A
P.Tod akler, Jr., M.D.
25.
McCarthy DM, Makler PT Jr, Waxman HL, Buxton AE, Horowitz LN, Spielman SR, Alavi A, Josephson ME: Fourier phase image during ventricular tachycardia:
Relationship to endocardial site of odgin. Clin Res 30:675,1982.
26.
Makler M Jr, Alavi A, McCarthy DM, Goldstein HA: Incidence of rapid resolution of stress-induced thallium defects. J Nucl Med 23:19,1982.
Presented at Society of Nuclear Medicine, Miami, Florida, June 1982.
27.
McCarthy DM, McFarland TM, Makler PT Jr, Josephson ME: Relationship between the site of origin of ventdcular tachycardia and relative myocardial perfusion and wall motion. J Nucl Med 23:81,1982.
I 28.
McCarthy DM, Makler PT Jr, Waxman HL, Buxton AE, Horowitz LN, Spielman SR, Alavi A, Josephson ME: Fourier phase image during ventricular tachycardia:
Relationship to endocardiiti site of origin. Circulation 66:271,1982.
29.
McCarthy DM, Makler PT Jr, Waxman HL, Buxton AE, Marchlinski FE, Horowitz LN, Spielman SR, Alavi A, Josephson ME: Fourier phase image during ventricular tachycardia: Relationship to endocardial site of crigm. J Am Coll Cardiol 1:712, 1983.
30.
Makler PT Jr, McCarthy DM, IGeaveland JP, Doherty JU, Goldstein EA, Velchik MG,' Alavi A: Fourier ventricular amplitude ratio to assess valvular regurgitation by gated blood pool scan. I Am Call Cardiol 1:711,1983.
Presented at American College of Cardiology, New Orleans, Louisiana, March 1983.
31.
Kleaveland J, Reichek N, Sutton MJ, Priest C, McCarthy DM, Makler PT Jr, Plappert T, Hirschfeld J: Failure of chronic load reduction to reverse left ventncular hypertrophy in aortic regurgitation. J Am Coll Cardiol 1:640,1983.
32.
Makler PT Jr, McCarthy DM, Goldstein HA, Alavi A: Early changes in thallium distribution: Effect on scan quantitation. J Nucl Med 24:46,1983.
Presented at Society of Nuclear Medicine, St. Louis, Missouri, June 1983.
33.
Makler PT Jr, McCarthy DM, Colvin C, Alavi A: Sources of variability in thallium circumferential profile curve analysis. J Nucl Med 24:45,1983.
Presented at Society of Nuclear Medicine, St. Louis, Missouri, June 1983.
34.
Makler PT Jr, McCarthy DM, Kleaveland JP, Doherty JU, Goldstein HA, Velchik MG, Alavi A: Fourier ventricular amplitude ratio to assess valvular regurgitation by gated blood pool scan. J Nucl Med 24:27,1983.
Presented at Society of Nuclear Medicine, St. Louis, Missouri, June 1983.
35.
Makler PT Jr, McCarthy DM, Bergey P, Marshall K, Born ML, Goldstein EA, Velchik MG, Alavi A: Multi-hospital survey of reliability of ejection fraction determination using a cardiac phantom. J Nucl Med 24:92,1983.
36.
McCanhy DM, Makler PT Jr, Muehllehner G, Alavi A: Slow infusion gated acquisition (SIGA): An alternative first pass method for determining left ventricular ejection fraction. J Nucl Med 24:88,1983.
12 a
P.Tod fakler, Jr., M.D.
37.
Velchik MG, Schwartz W, London JW, Makler FT Jr, Alavi A: Quantitadve analysis ofliver function in percutaneous transhepatic drainage patients. J Nucl Med 24:30,1983.
38.
McCarthy DM, Kleaveland JP, Makler FT Jr: Rad onuclide Fourier amplitude.
analysis ofleft ventricular aneurysm. Clin Res 31:668A,1983.
39.
McCarthy DM, Kleaveland JP, Makler FT Jr: Radionuclide Fourier amplitude analysis ofleft ventricular aneurysm. Circulation 68:137,1983.
l 40.
Kleaveland JP, McCarthy DM, Makler FT Jr, Hirschfeld JW Jr Alavi A, Reichek N: Raddonuclide evaluanon of aortic regurgitation at different levels of exercise.
Clin Res 31:196A,1983.
41.
McCarthy DM, Makler PT Jr, Waxman HL, Untereker WJ, Spielman SR, Alavi A, Josephson ME: Fourier phase image: Relationship [Res 31:205A,1983.
to endocardial activation in normal and abnormal ventdcular wall motion. Clm 42.
McCarthy DM, Kleaveland JP, Makier FT Jr: Radionuclide Fourier amplitude analysis to predict post-aneurysmectomy ejection fraction. J Am Coll Cardiol 3:590, 1984.
43.
Makler PT Jr, McCarthy DM, Adler L, Alavi A: Fourier ventricular amplitude ratio to evaluate atrial septal defect. Clin Res 32:187A,1984.
44.
McCarthy DM, Garibian GS, Muehllehner G, Makler PT Jr, Robinson GD Jr:
Myocardial perfusion imaging using rubidium-82 and a single crystal gamma camera. Clin Res 32:189A,1984.
45.
Velchik MG, Alavi A, Goldstein HA, Makler FT Jr: The value of the erect view in hepatic scintigraphy. Clin Res 32:287A,1984.
46.
McCarthy DM, Kleaveland JP, Makler PT Jr, Alavi A: Radionuclide Fourier amplitude analysis to predict post-aneurysmectomy ejection fraction. J Nucl Med 25:81, 1984.
47.
McCarthy Dh.vlakler PT Jr, Alavi A, Accuracy of ejection fraction by nuclear stethoscope in left ventricular aneurysm. J Nucl Med 25:81,1984.
48.
Hess DA, Makler FT Jr, McCarthy DM: Thallium scan quantitation in women.
Clin Res 32:673A,1984.
49.
Makler FT Jr, McCarthy DM, Adler L, Alavi A: Evaluation of atrial septal defect by Fourier ventdcular amplitude ratio. Clin Res 32:676A,1984.
Presented at American Federation of Clinical Research, Philadelphia, Pennsylvania, l
October 1984.
l 50.
McCr by DM, Muehllehner G, Garibian GS, Makler PT Jr, Robinson GD:
Simultaneous evaluation of myocardial perfusion and function with nibidium-82 and an Anger Camera. Clin Res 32:677A,1984.
1 13
q P. ?7 Makler, Jr., M.D.
b V
51.
McCarthy DM, Muehllehner G, Garibian GS, Makler PT Jr, Robinson GD:
Simultaneous evaluation of myocardial perfusion and function with rubidium-82 and an Anger Camera. Circulation 70:274,1984.
52.
McCarthy DM, Schwartz MH, Makler F Jr, Doherty JU, Josephson ME: Left ventricular functional impairment during ventricular tachycardia. J Am Coll Cardiol 5:532, 1985.
53.
Malder FT Jr, McCarthy DM, Adler L, Alavi A: Fourier ventricular amplitude ratio to evaluate atrial septal defect. J Nucl Med 26:74,1985.
54.
Alavi A, Kundel H, Mitchell S, Velchik MG, Malder FT Jr, Steinberg M, Kressel H: Comparison of radionuclide, computed tomography and magnetic resonance imaging of avascular necrosis of the hip using receiver operator characteristic curves. J Nucl Med 26:77,1985.
55.
Schwartz MH, McCarthy DM, Makler PT Jr: Isolated focal slow washout of thallium-201 as a cause of false-positive scans. J Nucl Med 26:84,1985.
56.
Schwartz MH, Makler FF Jr, McCarthy DM: Utility of exercise tolerance testing and quantitative T1-201 imaging to identify extensive coronary artery disease. Clin l
Res 33:748A.1985.
57.
Scheff A, Malder FF Jr: Clinical utility of Tc-99m aerosol lung scans in a community hospital setting. Clin Res 34:583A,1986 j
)
58.
Scheff A, Makler PT Jr: Technical aspects of performing Tc-99m aerosol lung scans in a R
community hospital setting. Clin Res 34:583A,1986 59.
Alavi A, Mitchell M, Kundel H, Steinberg M, Velchik M, Makler PT Jr, Kressel H, Axel L: Compadson of RN, MR1, XCTimaging in diagnosis of avascular necrosis of the femoral head. J Nucl Med 27:952,1986 60.
Scheff A, Makler PT Jr: The utility of the lateral lumbar spine radiograph in the determination of bone mineral density by dual photon absorptiometry.
Clin Res 35:325A,1987 61.
Schwartz MH, Makler PT Jr, McCarthy DM: Regional variation of planar thallium.
scintigraphy. Clin Res 35:325A,1987 62.
Schwartz MH, Wertheimer J, Makler PT Jr, Goldman A, Yazdanfar S, Nahkjavan FK:
Myocardialischemia after successful FTCA: Importance of thallium scans for follow-up.
l Clin Res 35:325A,1987 i
j 63.
Scheff AM, Morris ST, Horowitz GR, Makler PT, Strazhnik B: Differential Diagnosis of Probable Senile Dementia of the Alzheimer Type using Neurospect and Neuropsychological Tests. J Nucl Med 3,4:P115,1993 Editorials. Reviews and Chanters:
1.
Charkes ND, Brookes M, Makler PT Jr: Radiofluoride kinetics. In: Colombetti LG (Ed): Principles ofRadiophannacology. Volume 3. Boca Raton: CRC Press, Inc.,1979, pp. 225-242.
14 O
~
(v')
P.
Makler, Jr., M.D.
2.
Makler17F Jr: Nuclear medicine in urologic practice. In: Goldsmith HS (Ed):
Practice ofSurgery. Philadelphia: Harper and Row,1981.
3.
Charkes ND, Makler PT Jr Computer-simulated radionuclide bone scans in' health and disease using compartmental analysis techniques. In: Proceedings of the 1983 Smmner Computer Conference, Vancouver, British Columbia, July 11-13,1983.
4.
Makler PT Jr, Osbakken MD: Computers in nuclear cardiology. In: Osbakken, Reeves, Flickenger (Eds): Techniques, Diagnostics and Advances in Nuclear Cardiology. Springfield: Charles C. Thomas,1983.
5.
Makler PT JR, Schwartz M, Shapiro B, Scheff A: Maximizing thallium stress / redistribution scans (Letter to the Editor). J Nucl Med 32:1313-1314, June 1991.
6.
Makler PT Jr: Cardiovascular imaging with antibodies: Focus on antimyosin and antifibrin. In: Diagnostic Uses ofRadiclabeledMonoclonal Antibodies (Proceedings of a Symposium). American College of Nuclear Physicians,1992, pp 95-110.
Lectures hv Invitation:
1.
October 7,1980
" Thallium redistribution in myocardial sarcoidosis."
Greater New York Chapter of the Society of Nuclear Medicine, New York, New York 2.
October 15,1980
" Comparison of the stress thallium and stress wall motion tests."
Greater Delaware Valley Nuclear Cardiology Group, Philadelphia, Pennsylvania 3.
March 11,1981
" Comparison of computers in nuclear medicine."
Philadelphia Nuclear Medicine Conference, Philadelphia.
Pennsylvania 4.
April 14,1981
" Intervention in nuclear cardiology."
Greater New York Chapter of the Society of Nuclear Medicine, New York, New York 5.
October 24,1981
" Rapid resolution of stress induced thallium defects."
Greater New York Chapter of the Society of Nuclear Medicine, i
l Philadelphia, Pennsylvama.
6.
October 25,1981 "A new users approach to the nuclear stethoscope: Selection, validation, integration."
Users Symposium, Cherry Hill, New Jersey.
l 7.
April 14,1982 "New Uses of Computers."
l Philadelphia Nuclear Medicine Conference, Philadelphia, Pennsylvania 15 5
0
P. T Makler, Jr., M.D.
i,;
L/
8.
September 10,1982 " Thallium imaging update."
Greater New York Chapter of the Society of Nuclear Medicine, New York, New York 9.
September 12,1982 "Fouder am pool scan." plitude ratio to asses aortic regurgitation by gated blood Greater New York Chapter of the Society of Nuclear Medicine, New York, New York 10.
January 13,1983
" Phase analysis of gated blood pool studies."
Sloane Kettering Memorial Hospital, New York, New York 11.
March 9,1983
" Evaluating valvular disease."
Philadelphia Nuclear Medicine Conference, Philadelphia, Pennsylvania 12.
March 21,1983
" Newer aspects of gated blood pool scintigraphy."
Nuclear Medicine Update 1983, Kiawah Island, South Carolina 13.
March 21,1983
" Quantitating valvular insufficiency."
Nuclear Medicine Update 1983, Kiawah Island, South Carolina 14.
March 26,1983
" Assessment of valvular insufficiency."
Spring Symposium, Greater New York Chapter of the Society of Nuclear Medicine, Atlantic City, New Jersey 15.
March 26,1983
" Technique of Tl imaging: Role ofimage enhancement and quantification."
Spring Symposium, Greater New York Chapter of the Society of Nuclear Medicine, Atlantic City, New Jersey i
16.
May 21,1983
" Image analysis."
Pennsylvania College of Nuclear Medicine, Hershey, Pennsylvania 17.
December 14,1983
" Newer aspects of thallium imaging "
1 Philadelphia Nuclear Medicine Conference, Philadelphia, Pennsylvania 18.
May 1,1984
" Computers I."
Nuclear Medicine Update 1984, Orlando, Florida 19.
May 2,1984
" Computers II."
Nuclear Medicine Update 1984, Orlando, Florida 20.
May 2,1984
" Update on lung scanning."
Nuclear Medicine Update 1984, Orlando, Florida 21.
May 5,1984
" Phase analysis."
Technologist Refresher Course, Temple University Hospital, Philadelphia, Pennsylvania 16
P. Todd Makler, Jr., M.D.
o-o 22.
October 20,1984
" Quantitative evaluation of thallium: Help or hindrance?"
Greater New York Chapter of the Society of Nuclear Medicine, Philadelphia, Pennsylvania 23.
January 7,1985
" Bone densitometry."
Philadelphia Nuclear Medicine Conference, Philadelphia, Pennsylvania 4
24.
January 14,1985
" Evaluation of valvular insufficiency."
West Reading Hospital, Philadelphia, Pennsylvania 25.
March 30,1985
" Bone densitometry."
Spring Symposium, Greater New York Chapter of the Society of Nuclear Medicine, Philadelphia, Pennsylvania 26.
April 10,1985 "Xel33 vs. Xe123: Cost / benefit analysis."
Philadelphia Nuclear Medicine Conference, Philadelphia, Pennsylvania 27.
April 18,1985 "Uses and limitations of quantitative thallium scans."
Philadelphia Roentgen Ray Society Blue Ribbon Lecture, Philadelphia, Pennsylvania 28.
April 18,1985 "Quantification of valvular insufficiency."
[
Philadelphia Roentgen Ray Society Blue Ribbon Lecture, Philadelphia, Pennsylvania l
29.
October 25,1985 "Radionuclide ventriculograms in the evaluation of the failing l
valve."
l Greater New York and New England Chapters of the Society of Nuclear Medicine, Boston, Massachusetts 30.
November 21,1985 " Bone mineral density analysis by dual photon densitometry."
i l
Radiology Hospital, Garden State Hospital, Marlton, New Jersey 31, October 25,1985 "Radionuclide ventriculograms in the evaluation of the failing valve."
Greater New York Chapter of the Society of Nuclear Medicine, i
I Boston, Massachusetts 32.
February 12,1986
" Fourier phase analysis update."
Philadelphia Nuclear Medicine Conference, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania i
33.
March 26,1986 "Radionuclide Studies."
Panel Member, Ex-Residents Day, Albert Einstein Medical Center, Philadelphia, Pennsylvania l
34.
September 11,1986
" Evaluation of osteoporosis."
]
Temple University Hospital, Philadelphia, Pennsylvania I-17 L
,r
,__m.
P.To akler, Jr., M.D.
l 35.
September 27,1986
" Techniques and evaluation of osteoporosis, Part II."
Clinical Osteoporosis Evaluation Symposium, Mountainside l
Hospital, Montclair, New Jersey 1
36.
January 19,1987
" Photon absorptiometry: Basic concepts."-
Nuclear Medicme Update Conference, Acapulco, Mexico 37.
January 19,1987
" Cardiac computer applications."
Nuclear Medicine Update Conference, Acapulco, Mexico 38.
January 19,1987
" Cardiac blood poolimaging update."
Nuclear Medicine Update Conference, Acapulco, Mexico 39.
May 17,1989
" Clinical applications of SPECT."
Nuclear Medicine Continuing Education Program, Medica 1 Center of Delaware, Wilmington, Delaware 40.
June 12,1989
" Deep vein thrombosis detection using antifibrin antibody imaging."
Advances in the Use ofMonoclonal Antibodies in Nuclear Medicine Symposium, Society of Nuclear Medicine, St. Louis, Missouri 41.
October 20,1989 "SPECT: Why the time is now."
Greater New York Chapter of the Society of Nuclear Medicine, Philadelphia, Pennsylvania 42.
December 6,1990
" Role of monoclonal antibodies."
Healthcare Finance Association, Baltimore, Maryland 43.
September 26,1991 " Cardiovascular imaging with antibodies: Focus on antimyosin and antifibrin."
American College of Nuclear Physicians Symposium, Washington, DC 44.
October 19,1991
" Clinical uses of sestamibi."
Maryland Association of Nuclear Medicine, Baltimore Maryland 45.
April 13,1992
" Pharmacological stress testing."
Pennsylvania Society for Respiratory Care Annual Meeting, Philadelphia, Pennsylvania 46.
May 13,1992
" Myocardial scanning with cardiolite: Techniques and rationales."
Nuclear Cardiology Symposium, Pennsylvama Hospital, Philadelphia, Pennsylvama 47.
May 15,1993 "Tc-99m sestamibi myocardial perfusion scanning: Theory and practice."
l Temple University Hospital, Philadelphia, Pennsylvania l
48.
Dec 12,1995
" Dual Isotope Imaging of the Diabetic Foot": Toshiba Users Meeting, Philadelphia t
{
Letters to the Editor 18 i
P. TodP4kler, Jr., M.D.
CJ G
s
- 1. Re: Cost-effeef.veness of Noninvasive Testing for Osteomyelitis. JAMA, Oct. 4th,1995. 274, pg 1013
~
l 19
~
n*
,,\\
c
<G
'w )
(FOR LF MS USE )
INFORMATION FROM LTS BETWEEN:
LICENSE FEE MANAGEMENT BRANCH, ARM PROGRAM CODE: 22160 AND STATUS CODE: 0 REGIONAL LIC ENSING SECTIONS FEE CATEGORY: EX 7C EXP. DATE: 20020630 FEE CO M *1 EN T S : P ACEM AK E R / 2 9-12167- 01 DECOM FIN ASSUR REQD: N LICENSE FEE TRANSMITTAL A.
R E GIO N
[
1.
APPLICATION ATTACHE 0 A P PL IC A NT / L IC E N S E E :
KENNEDY MEMORIAL HOSPITALS RECEIVED D ATE:
770227 00CKET NO:
7002427 CONTROL NO.:
124319 LICENSE NO.:
AMENDMENT 2.
FEE ATTACHED AMOUNT:
CHECK NO.:
3.
COMMENTS l
SIGNED OATE M(-f[kh r et F M T. Q ll5ffT" ~ [i,/ )
B.
LICENSE FEE MANAGEMENT BRANCH (CHECK WHEN MILES w
i.
..._ _ _b_ _ _...... _ _ _
_ Y_.4_ h_e_h.. _...N. 4 7-c/'
1.
FEE C ATEGCRY AND AMOUNT:
j i
2.
CDRRECT FEE PAID.
A9PLp ATION M AY BE PROCESSED FOR:
AMeNonENT l
RENEWAL l
LICENSE 3.
OTHER SIGNED DATE
______________ ______________ ___N
'f G -
F l rqc'-p E E e
- lll f f,... ( N ifA-f. y
. ;.\\
z
( n 3,_ _
n v _ _ _ _ _ _ _.._ _y
,y,
\\-
y
- .., f
f
- c 1,
d